The quest for new antiparasitic alternatives has led researchers to base
their studies on insights into biology, host-parasite interactions and pathogenesis.
In this context, proteases and their inhibitors are focused, respectively, as
druggable targets and new therapy alternatives. Herein, we proposed to evaluate the
in vitro effect of the cysteine protease inhibitor E-64 on
Giardia trophozoites growth, adherence and viability.
Trophozoites (105) were exposed to E-64 at different final concentrations,
for 24, 48 and 72 h at 37 °C. In the growth and adherence assays, the number of
trophozoites was estimated microscopically in a haemocytometer, whereas cell
viability was evaluated by a dye-reduction assay using MTT. The E-64 inhibitor showed
effect on growth, adherence and viability of trophozoites, however, its better
performance was detected in the 100 µM-treated cultures. Although metronidazole was
more effective, the E-64 was shown to be able to inhibit growth, adherence and
viability rates by ≥ 50%. These results reveal that E-64 can interfere in some
crucial processes to the parasite survival and they open perspectives for future
investigations in order to confirm the real antigiardial potential of the protease
inhibitors.